Determinants of worse prognosis in patients with cardiac resynchronization therapy defibrillators. Are ventricular arrhythmias an adjunctive risk factor?
- Landolina, Maurizio
- Boriani, Giuseppe
- Biffi, Mauro
- Cattafi, Giuseppe
- Capucci, Alessandro
- Dello Russo, Antonio
- Facchin, Domenico
- Rordorf, Roberto
- Sagone, Antonio
- Del Greco, Maurizio
- Morani, Giovanni
- Nicolis, Daniele
- Meloni, Sarah
- Grammatico, Andrea
- Gasparini, Maurizio
Publication date
January 2021
DOI Publisher
Ovid Technologies (Wolters Kluwer Health)Abstract
Cardiac resynchronization therapy (CRT) is indicated in patients with systolic heart failure (HF), severe left ventricle (LV) dysfunction and interventricular dyssynchrony.In prospective observational research, we aimed to evaluate whether CRT-induced LV reverse remodelling and occurrence of ventricular arrhythmias (VT/VF) independently contribute to prognosis in patients with CRT defibrillators (CRT-D)
Add to ORKG